Clinical Trials Browser

Has results × Disease Progression × Clear all

NCT02533258 2025-07-16

Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice

13 enrolled 14 charts

Carcinoma, Renal Cell, Disease Progression

NCT02392078 2025-04-24

LAANTERN

1,153 enrolled 15 charts

Brain Neoplasms, Epilepsy, Movement Disorders, Disease Progression

NCT03154190 2025-01-24

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Phase NA Completed

128 enrolled 24 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Melanoma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Disease Progression, Triple Negative Breast Neoplasms

NCT04436120 2024-12-03

TRANSLATE

Phase NA Terminated

38 enrolled 17 charts

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Disease Progression

NCT01881620 2024-11-18

COMBITEP

Phase NA Completed

109 enrolled 12 charts

Disease Progression

NCT02043847 2024-11-13

BMT-03

Phase 1 Completed

12 enrolled 12 charts

Multiple Myeloma, Recurrence, Disease Progression

NCT03990571 2024-10-18

Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Phase 2 Completed

40 enrolled 13 charts

Carcinoma, Adenoid Cystic, Disease Progression

NCT01651078 2024-04-15

LAASR

44 enrolled 8 charts

Brain Neoplasms, Disease Progression

NCT04149821 2023-06-15

Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy

Phase 2 Terminated

1 enrolled 8 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Disease Progression

NCT03727841 2022-07-27

Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma

Phase 2 Terminated

4 enrolled 13 charts

Ependymoma, Disease Progression

NCT04033432 2022-04-27

sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Unknown

14 enrolled 13 charts

Prostatic Neoplasms, Disease Progression

NCT01109004 2021-12-09

BMT CTN 0702

Phase 3 Completed

758 enrolled 21 charts

Hematologic Diseases, Multiple Myeloma, Disease Progression

NCT02322320 2020-05-11

Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)

Phase 3 Completed

273 enrolled 16 charts

Hematologic Diseases, Multiple Myeloma, Disease Progression

NCT00995007 2016-03-29

A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

Phase 2 Completed

112 enrolled 12 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma, Disease Progression

NCT00108069 2015-11-05

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

Phase 2 Completed

43 enrolled 11 charts

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

NCT01778530 2015-10-07

TRC105 for Recurrent Glioblastoma

Phase 2 Terminated

2 enrolled 9 charts

Glioblastoma, Glioma, Disease Progression

NCT00908232 2015-01-15

SEQUENTIAL

Phase 2 Completed

163 enrolled 11 charts

Multiple Myeloma, Disease Progression, Bone Marrow Neoplasms

NCT00393094 2012-07-13

Bevacizumab and Irinotecan to Treat Brain Tumors

Phase 2 Terminated

31 enrolled 12 charts

Brain Neoplasms, Glioma, Disease Progression

NCT00171925 2012-04-11

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Phase 3 Terminated

143 enrolled 10 charts

Multiple Myeloma, Disease Progression